Celldex Therapeutics
CLDX
#4024
Rank
โ‚น321.27 B
Marketcap
โ‚น4,091
Share price
3.02%
Change (1 day)
133.23%
Change (1 year)

Revenue for Celldex Therapeutics (CLDX)

Revenue in 2026 (TTM): โ‚น74.83 Million

According to Celldex Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น82.45 Million. In 2025 the company made a revenue of โ‚น0.13 Billion a decrease over the revenue in the year 2024 that were of โ‚น0.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celldex Therapeutics from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น74.83 M-46.08%
2025 โ‚น0.13 B-76.95%
2024 โ‚น0.60 B5.1%
2023 โ‚น0.57 B193.78%
2022 โ‚น0.19 B-43.67%
2021 โ‚น0.34 B-36.17%
2020 โ‚น0.54 B112.89%
2019 โ‚น0.25 B-61.79%
2018 โ‚น0.66 B-18.05%
2017 โ‚น0.81 B76.47%
2016 โ‚น0.46 B26.59%
2015 โ‚น0.36 B60.26%
2014 โ‚น0.22 B-10.51%
2013 โ‚น0.25 B-58.59%
2012 โ‚น0.61 B25.14%
2011 โ‚น0.49 B-76.63%
2010 โ‚น2.09 B197.69%
2009 โ‚น0.70 B96.55%
2008 โ‚น0.35 B233.01%
2007 โ‚น0.10 B-50.73%
2006 โ‚น0.21 B57.15%
2005 โ‚น0.13 B-53.21%
2004 โ‚น0.29 B40.81%
2003 โ‚น0.21 B-34.4%
2002 โ‚น0.32 B99.15%
2001 โ‚น0.16 B353.26%
2000 โ‚น35.61 M-42.76%
1999 โ‚น62.22 M-33.48%
1998 โ‚น93.54 M83.1%
1997 โ‚น51.08 M18.43%
1996 โ‚น43.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น6.028 T 7,310,985.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.543 T 4,297,821.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.204 T 5,099,744.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น219.01 B 265,529.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น11.79 B 14,203.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น61.48 B 74,472.75%๐Ÿ‡บ๐Ÿ‡ธ USA